Compare IDEXX Laboratories, Inc. (IDXX) vs KraneShares CSI China Internet ETF (KWEB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs KraneShares CSI China Internet ETF — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while KraneShares CSI China Internet ETF trades at $24.93 (market cap $4.37B). The key difference: IDEXX Laboratories, Inc. is far larger — about 9.3× KraneShares CSI China Internet ETF's market cap, and IDEXX Laboratories, Inc. is more actively traded (692,164 versus 13,393,361). Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and KraneShares CSI China Internet ETF for 57 Days on average.
| IDXX | KWEB | |
|---|---|---|
Market Cap | $40.43B | $4.37B |
Volume | 692,164 | 13,393,361 |
Sector | Health | Sector/Thematic |
52-Week High | $766.68 | $41.35 |
52-Week Low | $504.70 | $23.63 |
Typical Hold Time | 46 Days | 57 Days |
Enterprise Value | $41.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
KWEB, the KraneShares CSI China Internet ETF, trades at $24.025, down 1.25% amid bearish technical signals with all 13 moving averages indicating sell pressure. The ETF faces headwinds from China's economic challenges including industrial overcapacity and weak domestic consumption, though recent institutional activity shows mixed positioning with some firms reducing stakes while others increase exposure ahead of potential trade developments.
The outlook remains cautious given China's macroeconomic pressures and ongoing U.S.-China trade tensions, though corporate profits surged 26% in Q2 2026. Key risks include global protectionism against Chinese exports and regulatory uncertainty, while potential trade agreement progress could provide catalysts for the battered Chinese internet sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About KraneShares CSI China Internet ETF
KWEB tracks the CSI Overseas China Internet Index, providing exposure to Chinese software and services companies listed in the US and Hong Kong, including giants like Tencent, Alibaba, and Meituan.
Read more on KWEB →
